S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

Gracell Biotechnologies (GRCL) News Today

$10.25
0.00 (0.00%)
(As of 02/22/2024)
SourceHeadline
finance.yahoo.com logoGRCL Mar 2024 10.000 call(CONTR
finance.yahoo.com - March 3 at 12:04 AM
marketbeat.com logo49,158 Shares in Gracell Biotechnologies Inc. (NASDAQ:GRCL) Purchased by Pathstone Family Office LLC
marketbeat.com - February 24 at 4:27 AM
finance.yahoo.com logoGracell Biotechnologies Acquisition Completed
finance.yahoo.com - February 22 at 10:23 AM
marketbeat.com logoGracell Biotechnologies (NASDAQ:GRCL) Given Hold Rating at Stifel Nicolaus
marketbeat.com - February 22 at 9:38 AM
globenewswire.com logoGracell Biotechnologies Acquisition Completed
globenewswire.com - February 22 at 8:45 AM
marketbeat.com logo
marketbeat.com - February 22 at 6:11 AM
marketbeat.com logoBarclays PLC Increases Stake in Gracell Biotechnologies Inc. (NASDAQ:GRCL)
marketbeat.com - February 22 at 4:14 AM
seekingalpha.com logoAstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)
seekingalpha.com - February 21 at 11:51 AM
investing.com logoGracell Biotechnologies Inc. (GRCL)
investing.com - February 21 at 1:55 AM
marketbeat.com logoStock Traders Buy High Volume of Gracell Biotechnologies Put Options (NASDAQ:GRCL)
marketbeat.com - February 20 at 11:33 AM
finanznachrichten.de logoGracell Biotechnologies Inc.: Gracell Biotechnologies Announces Shareholders' Approval of Merger Agreement
finanznachrichten.de - February 20 at 10:43 AM
finance.yahoo.com logoGracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
finance.yahoo.com - February 20 at 10:43 AM
globenewswire.com logoGracell Biotechnologies Announces Shareholders' Approval of Merger Agreement
globenewswire.com - February 20 at 7:45 AM
finance.yahoo.com logoGRCL Mar 2024 2.500 call
finance.yahoo.com - February 17 at 6:25 PM
seekingalpha.com logoGRCL Gracell Biotechnologies Inc.
seekingalpha.com - February 17 at 8:24 AM
marketbeat.com logoGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Rating of "Moderate Buy" by Brokerages
marketbeat.com - February 10 at 1:29 AM
marketbeat.com logoGracell Biotechnologies (NASDAQ:GRCL) Sets New 12-Month High at $10.36
marketbeat.com - February 9 at 3:55 PM
marketbeat.com logoGracell Biotechnologies Inc. (NASDAQ:GRCL) is Vivo Capital LLC's 9th Largest Position
marketbeat.com - February 6 at 1:39 PM
finance.yahoo.com logoGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
finance.yahoo.com - January 29 at 9:45 AM
marketbeat.com logoAstraZeneca: Rebound in 2024 with double-digit earnings growth (GRCL)
marketbeat.com - January 11 at 6:20 AM
finance.yahoo.com logoGracell Biotechnologies Inc. Sponsored ADR (GRCL) is a Great Momentum Stock: Should You Buy?
finance.yahoo.com - January 3 at 5:36 PM
businesswire.com logoGRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
businesswire.com - December 31 at 11:28 PM
marketbeat.com logoBarclays PLC Trims Stock Position in Gracell Biotechnologies Inc. (NASDAQ:GRCL)
marketbeat.com - December 30 at 4:10 AM
marketbeat.com logoGracell Biotechnologies Inc. to Post FY2026 Earnings of ($0.82) Per Share, HC Wainwright Forecasts (NASDAQ:GRCL)
marketbeat.com - December 29 at 7:38 AM
marketbeat.com logoGracell Biotechnologies (NASDAQ:GRCL) Earns "Equal Weight" Rating from Wells Fargo & Company
marketbeat.com - December 27 at 1:25 PM
markets.businessinsider.com logoMaintaining Hold on Gracell Biotechnologies Amidst AstraZeneca Acquisition Prospects
markets.businessinsider.com - December 27 at 8:23 AM
msn.com logoWhy China-Based Gracell Biotechnologies (GRCL) Stock Is Soaring Today
msn.com - December 26 at 8:41 PM
finance.yahoo.com logoGracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
finance.yahoo.com - December 26 at 8:41 PM
marketbeat.com logoGracell Biotechnologies (NASDAQ:GRCL) Stock Rating Reaffirmed by BTIG Research
marketbeat.com - December 26 at 12:27 PM
markets.businessinsider.com logoGracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
markets.businessinsider.com - December 26 at 9:26 AM
tmcnet.com logoGRCL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Gracell Biotechnologies Inc. Is Fair to Shareholders
tmcnet.com - December 26 at 9:26 AM
marketbeat.com logoGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Average Recommendation of "Buy" by Brokerages
marketbeat.com - December 22 at 2:20 AM
finance.yahoo.com logoGracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
finance.yahoo.com - December 21 at 10:13 AM
finance.yahoo.com logoGracell Biotechnologies Inc. Sponsored ADR (GRCL) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - December 21 at 10:13 AM
marketbeat.com logoPivotal bioVenture Partners Investment Advisor LLC Invests $3.96 Million in Gracell Biotechnologies Inc. (NASDAQ:GRCL)
marketbeat.com - December 18 at 1:42 PM
marketbeat.com logoGracell Biotechnologies Inc. (NASDAQ:GRCL) Short Interest Update
marketbeat.com - December 16 at 7:35 PM
finance.yahoo.com logoGracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023
finance.yahoo.com - December 12 at 12:02 AM
finance.yahoo.com logoWall Street Analysts Believe Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Could Rally 127.82%: Here's is How to Trade
finance.yahoo.com - December 11 at 2:01 PM
finance.yahoo.com logoInstitutions own 19% of Gracell Biotechnologies Inc. (NASDAQ:GRCL) shares but private equity firms control 45% of the company
finance.yahoo.com - December 2 at 10:23 AM
markets.businessinsider.com logoBuy Rating for Gracell Biotechnologies on Promising CAR-T Cell Therapy Advancements
markets.businessinsider.com - November 29 at 1:20 AM
msn.com logoEvercore ISI Group Initiates Coverage of Gracell Biotechnologies Inc - ADR (GRCL) with Outperform Recommendation
msn.com - November 28 at 3:20 PM
marketwatch.com logoGracell Biotechnologies Shares Rise 9%, FDA Clears Application for Lupus Treatment
marketwatch.com - November 27 at 11:23 PM
markets.businessinsider.com logoGracell Biotechnologies: FDA Clears IND Application For Phase 1/2 Trial Of FasTCAR-T GC012F
markets.businessinsider.com - November 27 at 1:13 PM
finance.yahoo.com logoGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
finance.yahoo.com - November 27 at 1:13 PM
finance.yahoo.com logoWhat Makes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) a Strong Momentum Stock: Buy Now?
finance.yahoo.com - November 23 at 6:02 PM
finance.yahoo.com logoDoes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Have the Potential to Rally 120.94% as Wall Street Analysts Expect?
finance.yahoo.com - November 23 at 1:02 PM
finanznachrichten.de logoGracell Biotechnologies Inc.: Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
finanznachrichten.de - November 16 at 1:00 PM
finance.yahoo.com logoGracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
finance.yahoo.com - November 16 at 1:00 PM
markets.businessinsider.com logoPositive Outlook for Gracell Biotechnologies: Promising Translational Data and Financial Stability Backs Buy Rating
markets.businessinsider.com - November 14 at 11:57 PM
markets.businessinsider.com logoGracell Biotechnologies: Promising Developments in Systemic Lupus Erythematosus Treatment Augment Buy Rating
markets.businessinsider.com - November 14 at 8:55 AM
Get Gracell Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter.

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

GRCL Media Mentions By Week

GRCL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRCL
News Sentiment

0.00

0.66

Average
Medical
News Sentiment

GRCL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRCL Articles
This Week

0

2

GRCL Articles
Average Week

Get Gracell Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GRCL) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners